Cubist Systematic Strategies’s Axsome Therapeutics AXSM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16.6M | Sell |
159,233
-18,581
| -10% | -$1.94M | 0.08% | 145 |
|
|
2025
Q1 | $20.7M | Buy |
177,814
+60,877
| +52% | +$7.1M | 0.13% | 64 |
|
|
2024
Q4 | $9.89M | Buy |
+116,937
| New | +$9.89M | 0.06% | 183 |
|
|
2024
Q2 | – | Sell |
-60
| Closed | -$4.79K | – | 1504 |
|
|
2024
Q1 | $4.79K | Buy |
+60
| New | +$4.79K | ﹤0.01% | 2068 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 2149 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 1994 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 2293 |
|
|
2023
Q1 | – | Sell |
-9,199
| Closed | -$710K | – | 2847 |
|
|
2022
Q4 | $710K | Sell |
9,199
-66,634
| -88% | -$5.14M | ﹤0.01% | 1972 |
|
|
2022
Q3 | $3.38M | Buy |
75,833
+42,465
| +127% | +$1.89M | 0.02% | 1137 |
|
|
2022
Q2 | $1.28M | Buy |
33,368
+14,902
| +81% | +$571K | 0.01% | 1930 |
|
|
2022
Q1 | $764K | Sell |
18,466
-9,725
| -34% | -$402K | 0.01% | 2237 |
|
|
2021
Q4 | $1.07M | Sell |
28,191
-19,093
| -40% | -$721K | 0.01% | 1863 |
|
|
2021
Q3 | $1.56M | Buy |
+47,284
| New | +$1.56M | 0.02% | 1207 |
|
|
2021
Q2 | – | Sell |
-16,823
| Closed | -$953K | – | 2917 |
|
|
2021
Q1 | $953K | Buy |
16,823
+14,413
| +598% | +$816K | 0.01% | 1570 |
|
|
2020
Q4 | $196K | Buy |
2,410
+306
| +15% | +$24.9K | ﹤0.01% | 2244 |
|
|
2020
Q3 | $150K | Sell |
2,104
-3,241
| -61% | -$231K | ﹤0.01% | 2204 |
|
|
2020
Q2 | $440K | Buy |
5,345
+2,237
| +72% | +$184K | 0.01% | 1647 |
|
|
2020
Q1 | $183K | Sell |
3,108
-16,578
| -84% | -$976K | ﹤0.01% | 1768 |
|
|
2019
Q4 | $2.04M | Buy |
19,686
+15,260
| +345% | +$1.58M | 0.04% | 740 |
|
|
2019
Q3 | $90K | Sell |
4,426
-11,083
| -71% | -$225K | ﹤0.01% | 1956 |
|
|
2019
Q2 | $399K | Buy |
+15,509
| New | +$399K | 0.01% | 1624 |
|